top of page


Alexiades-Armenakas, M.R., Ramsay, D. and Kopf, A.W. The appropriateness of curettage and electrodessication for the treatment of basal cell carcinomas. Arch Dermatol 2000 Jun; 136 (6): 800.


The ever-increasing role of ALA-PDT: A roundtable discussion on the current state and future direction of photodynamic therapy and 5-aminolevulinic acid.  Skin & Aging, March 2005, 42-51.


Alexiades-Armenakas, M.R. Laser News. Journal of Drugs in Dermatology. 2005-present.


Alexiades-Armenakas, M. Laser and light technology and phototherapy.
J Drugs Dermatol 2005 Jul-Aug;4(4):514-5.


Alexiades-Armenakas, M. Intense pulsed light-mediated photodynamic therapy.
J Drugs Dermatol 2005 Sep-Oct;4(5):657-8.


Alexiades-Armenakas, M. New and emerging treatments in laser and light.
J Drugs Dermatol 2006 Jan; 5(1): 85.


Alexiades-Armenakas M. Laser-mediated photodynamic therapy. Clin Dermatol 2006 Jan-Feb; 24 (1): 16-25.


Alexiades-Armenakas M.R. Laser skin tightening: non-surgical alternative to the face-lift. J Drugs Dermatol 2006 Mar; 5(3): 295-6.


Alexiades-Armenakas M.R. Update on soft tissue augmentation. J Drugs Dermatol 2006 May; 5(5).


Alexiades-Armenakas M.R. Laser hair removal. J Drugs Dermatol 2006 July-Aug; 5(7): 678-9.


Alexiades-Armenakas M. Laser and light-based treatment of cellulite. J Drugs Dermatol 2007 Jan; 6(1): 83-4.


Alexiades-Armenakas M. What is new in lasers and cosmetic procedures from the 2007 AAD annual meeting. J Drugs Dermatol 2007 Jan; 6(4):464.


Alexiades-Armenakas M. Fractional laser resurfacing. J Drugs Dermatol 2007 Jul; 6(7): 750-1.


Alexiades-Armenakas M. Nanotechnology. J Drugs Dermatol 2007 Nov; 6 (11): 1155-56.

Alexiades-Armenakas M. Parabens toxicity to skin and other organs. J Drugs Dermatol Jan 2008; 7 (1): 77-78.


Alexiades-Armenakas M. Sunscreen use in photodynamic therapy protocols. Derm Surg. In Press.


Alexiades-Armenakas M. Somatic stem cells in dermatology. J Drugs Dermatol March 2008.


Alexiades-Armenakas M.R. Retrograde transport and transcytosis of botulinum toxin serotypes to the brain: analysis of potential neurotoxicity. J Drugs Dermatol Oct 2008; 7 (10).


Alexiades-Armenakas M. Melanoma-detecting technologies and standard of care. J Drugs Dermatol 2012 Nov;11(11):1270-1.


Alexiades-Armenakas M. Commentary: fractional laser resurfacing to enhance skin permeation. Dermatol Surg. 2012 Aug;38(8):1294-5. doi: 10.1111/j.1524-4725.2012.02403.x.


Alexiades-Armenakas M. Combination of light and energy-based technologies with topical drug delivery. J Drugs Dermatol. 2013 Nov;12(11):1208. .

bottom of page